메뉴 건너뛰기




Volumn 6, Issue 4, 2000, Pages 221-224

Clinical and laboratory improvement in ankylosing spondylitis after treatment with etanercept: A case report

Author keywords

Ankylosing spondylitis; Etanercept (Enbrel); Tumor necrosis factor

Indexed keywords

ETANERCEPT; SALAZOSULFAPYRIDINE;

EID: 0033886315     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200008000-00011     Document Type: Article
Times cited : (9)

References (16)
  • 12
    • 0027198002 scopus 로고
    • Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
    • (1993) J Immunol , vol.151 , pp. 1548-1561
    • Mohler, K.M.1    Torrance, D.S.2    Smith, C.A.3
  • 16
    • 85037928520 scopus 로고    scopus 로고
    • Phase III trial of etanercept vs. methotrexate (MTX) in active early rheumatoid arthritis (ENBRELERA trial). Presentation at the American College of Rheumatology 63rd National Scientific Meeting, Boston, MA; 1999 November 14. Abstract 280
    • Finck, B.1    Martin, R.2    Fleischmann, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.